Blue Star Subsidiary Sells MedTech Division for up to ₹40 Cr
Blue Star Engineering & Electronics Limited, a wholly owned subsidiary of Blue Star Ltd, has executed a Business Transfer Agreement (BTA) with Cyrix Healthcare Private Limited to sell its MedTech division. The division, which deals in high-end medical diagnostic equipment and services, generated ₹42.13 crores in income for FY26, representing 0.33% of the company's consolidated income. The net worth of the division was approximately ₹7.11 crores as of March 31, 2026. The sale, structured as a slump sale, is expected to be completed by March 31, 2027, with a consideration of up to ₹40 crores. Cyrix Healthcare is not part of Blue Star's promoter group, and the transaction is not considered a related party transaction.
Key Highlights
- Subsidiary Blue Star E&E sells MedTech division to Cyrix Healthcare.
- Transaction value up to ₹40 crores.
- MedTech division contributed 0.33% of consolidated income in FY26.
- Sale expected to complete by March 31, 2027.
- Deal is a slump sale of a going concern.
Price Impact
More from BLUESTARCO